IP Library Granted Patent US 11,279,913
Granted Patent B2
US 11,279,913 · App. 15/875,679 · Granted Mar 22, 2022

Sperm processing method, apparatus and related media compositions

Inventors: Thomas B. Gilligan (College Station, TX); Clara Gonzalez-Marin (College Station, TX); Ramakrishnan Vishwanath (Hamilton, NZ)
Assignee: Inguran, LLC
C12N5/0612A01N1/0205A01N1/0215A01N1/0221A01N1/0226
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,279,913
App. No.
15/875,679
Granted
Mar 22, 2022
Kind
B2
Abstract

Embodiments of the present invention relate generally to processes, systems, and compositions useful in manipulating a ratio of viable X chromosome bearing sperm to viable Y chromosome bearing sperm in at least one sperm population and useful for preserving the resulting manipulated sperm population. In some embodiments a cryoprotectant may be incorporated into various medias used in manipulating the sperm sample, such as in a staining media, a sheath fluid, and a collection media.

Claims (41)

1. A method of increasing resolution while analyzing sperm comprising:

staining a sperm sample having viable X-chromosome bearing sperm and viable Y-chromosome bearing sperm with a staining media;

contacting the stained sperm sample with a sheath fluid in a flow path; and

manipulating a ratio of viable X-chromosome bearing sperm to viable Y-chromosome bearing sperm to form at least one manipulated sperm population;

the sheath fluid comprising cryoprotectant comprising a polyalcohol, the polyalcohol at a vol./vol. or wt./vol. concentration between about 0.1% and about 6% in the sheath fluid thereby increasing resolution.

2. The method of claim 1 further comprising the step of collecting the manipulated sperm population in a collection media.

3. The method of claim 2 , wherein the collection media comprises an amount of cryoprotectant.

4. The method of claim 2 , wherein each of the staining media, the sheath fluid and the collection media include an amount of cryoprotectant.

5. The method of claim 1 , wherein the step of manipulating a ratio of viable X-chromosome bearing sperm to viable Y-chromosome bearing sperm to form at least one manipulated sperm population further comprises either selecting sperm for separation and collection or for photo-damage and collection.

6. The method of claim 1 further comprising the step of freezing the manipulated sperm sample.

7. The method of claim 1 , further comprising one or more of the following processing steps: holding; transporting; buffering; chilling; warming; diluting; concentrating; exciting with a laser; charging; deflecting; ablating; collecting; shaking; oscillating; magnetically separating; oxygenating; labeling; precipitating; centrifuging; resuspending; mixing; dialyzing; cryostabilizing; microchip processing; and flow cytometry processing.

8. The method of claim 1 , wherein the polyalcohol is selected from the group consisting of: ethylene glycol; glycerol; erythritol; threitol; arabitol; ribitol; xylitol; sorbitol; galactitol; iditol; volemitol; fucitol; inositol; a glycylglycitol, and combinations thereof.

9. The method of claim 1 , wherein the polyalcohol is selected from the group consisting of: propylene glycol, butane triol and combinations thereof.

10. The method of claim 1 , wherein at least one of the sheath fluid and the staining media further comprises an antioxidant.

11. The method of claim 10 , wherein the antioxidant comprises an antioxidant selected from the group consisting of: pyruvate, vitamin B12; vitamin B12 vitamers; vitamin E; vitamin E vitamers; tocopherol; tocotrienol; α-tocophery; alpha ketoglutarate; derivatives thereof and combinations thereof.

12. The method of claim 1 , wherein the sheath fluid comprises the cryoprotectant at a vol./vol. or wt./vol. concentration between about 0.1% and about 2%; between about 2% and about 4%; between about 4% and about 6%; between about 1% and about 2%; between about 2% and about 3%; between about 3% and about 4%; between about 4% and about 5%; between about 5% and about 6%; between about 2% and about 6%; or between about 3% and about 5%.

13. The method of claim 1 , wherein the sheath fluid comprises a saline buffered with phosphates, TRIS citrate, or HEPES.

14. The method of claim 1 , wherein cryoprotectant is added to the staining media in a first amount and added to the sheath fluid in a second amount, and wherein the second amount is greater than the first amount.

15. The method of claim 1 , wherein increasing resolution comprises increasing a peak to valley ratio formed by the viable X-chromosome bearing sperm and the viable Y-chromosome bearing sperm.

16. The method of claim 1 , wherein the step of manipulating comprises sorting the sperm sample at an event rate of at least 20,000 events per second.

17. A method of processing sperm comprising:

staining a sperm sample with a staining media having a DNA selective dye;

injecting the stained sperm sample into a flow of sheath fluid;

exposing the stained sperm sample in the flow of sheath fluid to an electromagnetic radiation source which causes a detectable response in the DNA selective dye;

detecting the response of the DNA selective dye to the electromagnetic radiation exposure;

manipulating a ratio of viable X-chromosome bearing sperm to viable Y-chromosome bearing sperm to form at least one manipulated sperm population; and

collecting the at least one manipulated sperm population in one or more collection vessels having collection medias therein;

the staining media, the sheath fluid and the collection medias comprising a cryoprotectant, the cryoprotectant comprising a polyalcohol.

18. The method of claim 17 , wherein the staining media comprises a first amount of the cryoprotectant, the sheath fluid comprises a second amount of the cryoprotectant, and the collection media comprises a third amount of the cryoprotectant.

19. The method of claim 18 , wherein the first amount of the cryoprotectant is less than the second amount of the cryoprotectant and the third amount of the cryoprotectant.

20. The method of claim 18 , wherein the third amount of the cryoprotectant is greater than the first amount of the cryoprotectant and the second amount of the cryoprotectant.

21. The method of claim 17 , wherein the polyalcohol is selected from the group consisting of: ethylene glycol; glycerol; erythritol; threitol; arabitol; ribitol; xylitol; sorbitol; galactitol; iditol; volemitol; fucitol; inositol; a glycylglycitol, and combinations thereof.

22. The method of claim 17 , wherein the polyalcohol is selected from the group consisting of: propylene glycol, butane triol and combinations thereof.

23. The method of claim 17 , wherein at least one of the sheath fluid, the staining media and the collection media further comprises an antioxidant.

24. The method of claim 23 , wherein the antioxidant comprises an antioxidant selected from the group consisting of: vitamin B12; vitamin B12 vitamers; vitamin E; vitamin E vitamers; tocopherol; tocotrienol; α-tocophery; alpha ketoglutarate; derivatives thereof and combinations thereof.

25. The method of claim 17 , wherein at least one of the sheath fluid, the staining media, and the collection media further comprises a citrate, citric acid, citric acid monohydrate, or sodium citrate.

26. The method of claim 17 , wherein the sheath fluid comprises the cryoprotectant at a vol./vol. or wt./vol. concentration between about 0.1% and about 6%.

27. The method of claim 17 , wherein the sheath fluid comprises the cryoprotectant at a vol./vol. or wt./vol. concentration between about 0.1% and about 2%; between about 2% and about 4%; between about 4% and about 6%; between about 1% and about 2%; between about 2% and about 3%; between about 3% and about 4%; between about 4% and about 5%; between about 5% and about 6%; between about 2% and about 6%; or between about 3% and about 5%.

28. The method of claim 17 , wherein the staining media comprises the cryoprotectant at a vol./vol. or wt./vol. concentration between about 0.1% and about 1%; between about 1% and about 2%; between about 2% and about 3%; between about 3% and about 4%; between about 2% and about 4%; or between about 1.5% and about 3%.

29. The method of claim 17 , wherein the collection media comprises the cryoprotectant at a vol./vol. or wt./vol. concentration between about 1% and about 2%; between about 2% and about 4%; between about 4% and about 6%; between about 3% and about 5%; or between about 3.5% and about 5.5%; or at about 4.5%.

30. The method of claim 17 , wherein the sheath fluid comprises a saline buffered with phosphates, TRIS citrate, or HEPES.

Assignments (3)
SECURITY INTEREST Recorded Nov 24, 2025
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073783/0924 →
SECURITY INTEREST Recorded Mar 31, 2021
From: INGURAN, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055791/0492 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 24, 2018
From: GILLIGAN, THOMAS B.; GONZALEZ-MARIN, CLARA; VISHWANATH, RAMAKRISHNAN
To: INGURAN, LLC
Reel/Frame 044717/0845 →